| http://dbpedia.org/ontology/abstract
|
Die Sinopharm Group ist ein chinesisches P … Die Sinopharm Group ist ein chinesisches Pharmaunternehmen. Die Muttergesellschaft der Sinopharm Group war Sinopharm Industrial Investment, ein 51 zu 49-Joint Venture zwischen der staatlichen und der privaten Fosun Pharmaceutical. Die Sinopharm-Gruppe erforscht und entwickelt, produziert, vertreibt und vermarktet Arzneimittel und andere Gesundheitsprodukte. Die Sinopharm Group verwaltet Fabriken, Forschungslabors, Plantagen der traditionellen chinesischen Medizin sowie Marketing- und Vertriebsnetzwerke, die sich über ganz China erstrecken. Seit 2009 ist die H-Aktie des Unternehmens an der Hongkonger Börse notiert. Der Börsengang betrug 16 HK-Dollar je Aktie. Die Tochtergesellschaft der Sinopharm Group, , und fungierten als Gegenstück der A-Aktie. Die A-Aktie der Sinopharm Group selbst war jedoch nicht notiert. Die Sinopharm-Gruppe lag 2017 auf Platz 194, 2020 auf Platz 169 unter den 500 umsatzstärksten Unternehmen weltweit. Sinopharm hat mit BBIBP-CorV und zwei SARS-CoV-2-Impfstoffe entwickelt. Stand Ende März 2021 wurden von diesen Impfstoffen nach firmeneigenen Angaben weltweit 80 Millionen Dosen verabreicht. Im Mai 2021 erhielt der Impfstoff BBIBP-CorV eine Notfallzulassung der Weltgesundheitsorganisation.zulassung der Weltgesundheitsorganisation.
, Sinopharm Group Co., Ltd. är ett kinesiskt … Sinopharm Group Co., Ltd. är ett kinesiskt läkemedelsföretag. Dess huvudägare är Sinopharm Industrial Investment, ett samriskföretag mellan det statliga och det privata . Sinopharm Group forskar om och utvecklar och tillverkar mediciner och vacciner. Företaget är sedan 2009 noterat på Hongkongbörsen.t är sedan 2009 noterat på Hongkongbörsen.
, Sinopharm Group Co., Ltd. (國藥控股股份有限公司, «Си … Sinopharm Group Co., Ltd. (國藥控股股份有限公司, «Синофарм Груп» или «Синофарм Холдинг») — одна из крупнейших фармацевтических компаний Китая и Азии; входит в «большую тройку» фармацевтических компаний страны (наряду с China Resources Pharmaceutical Group и Shanghai Pharmaceuticals) и в сотню крупнейших компаний Китая. Основана в 2003 году, штаб-квартира расположена в Шанхае, контрольный пакет принадлежит China National Pharmaceutical Group. Sinopharm Group специализируется на дистрибуции и логистике фармацевтической и медицинской продукции китайских и международных компаний, на розничных продажах лекарств через сеть аптек, на дистрибуции и лизинге медицинского оборудования, на производстве фармацевтической продукции, химических реагентов и лабораторных материалов. Sinopharm Group заняла 829-е место в списке Forbes Global 2000 за 2016 год.о в списке Forbes Global 2000 за 2016 год.
, 國藥控股股份有限公司（英文名：Sinopharm Group Co., Ltd.，簡稱：“國藥控股”，港交所：1099）是中國國藥集團旗下的核心企業。
, Sinopharm est un groupe pharmaceutique chi … Sinopharm est un groupe pharmaceutique chinois fondé en 2003. C'est la plus grande entreprise pharmaceutique en Chine, détenue conjointement par la China National Pharmaceutical Group Corporation et Fosun International. Son chiffre d'affaires en 2013 a atteint les 33,2 milliards de dollars US. Ils développent le vaccin BBIBP-CorV, à particules virales inactivées lors de la Pandémie de Covid-19.nactivées lors de la Pandémie de Covid-19.
, O Sinopharm Group é uma empresa farmacêuti … O Sinopharm Group é uma empresa farmacêutica chinesa. As empresas controladoras do Grupo Sinopharm são a Sinopharm Industrial Investment, uma joint venture do China National Pharmaceutical Group, de propriedade estatal, e a Fosun Pharmaceutical, empresa privada.e a Fosun Pharmaceutical, empresa privada.
, Sinopharm Group Co., Ltd. is a Chinese pha … Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted. Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list.ked 829th in 2016 Forbes Global 2000 list.
, Sinopharm Group, Txinako sendagai biologiko arloko produktuen enpresa bat da. 2003an sortua, Shanghai hirian egoitza nagusia du.
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Sinopharm_Group_logo.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
21280820
|
| http://dbpedia.org/ontology/wikiPageLength
|
13660
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1117952037
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/United_Arab_Emirates +
, http://dbpedia.org/resource/Category:Chinese_brands +
, http://dbpedia.org/resource/President_%28corporate_title%29 +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/China_National_Pharmaceutical_Group +
, http://dbpedia.org/resource/COVAX +
, http://dbpedia.org/resource/World_Health_Organization +
, http://dbpedia.org/resource/Pakistan +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2003 +
, http://dbpedia.org/resource/Sinopharm_CNMC +
, http://dbpedia.org/resource/Egypt +
, http://dbpedia.org/resource/Morocco +
, http://dbpedia.org/resource/Pharmaceutical_industry_in_China +
, http://dbpedia.org/resource/CoronaVac +
, http://dbpedia.org/resource/Category:Retail_companies_of_China +
, http://dbpedia.org/resource/Category:Companies_based_in_Shanghai +
, http://dbpedia.org/resource/JAMA +
, http://dbpedia.org/resource/COVID-19_vaccine +
, http://dbpedia.org/resource/Pharmaceutical +
, http://dbpedia.org/resource/State-owned_enterprise +
, http://dbpedia.org/resource/Shanghai +
, http://dbpedia.org/resource/Category:Government-owned_companies_of_China +
, http://dbpedia.org/resource/H_shares +
, http://dbpedia.org/resource/Peru +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Bahrain +
, http://dbpedia.org/resource/Forbes_Global_2000 +
, http://dbpedia.org/resource/Inactivated_vaccine +
, http://dbpedia.org/resource/Fosun_Pharmaceutical +
, http://dbpedia.org/resource/A-share_%28mainland_China%29 +
, http://dbpedia.org/resource/Argentina +
, http://dbpedia.org/resource/Initial_public_offering +
, http://dbpedia.org/resource/Category:Chinese_companies_established_in_2004 +
, http://dbpedia.org/resource/Hong_Kong_Stock_Exchange +
, http://dbpedia.org/resource/Pharmaceutical_company +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Hong_Kong_Stock_Exchange +
, http://dbpedia.org/resource/Category:Fosun_International +
, http://dbpedia.org/resource/Category:Privatization_in_China +
, http://dbpedia.org/resource/Civilian-run_enterprise +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_China +
, http://dbpedia.org/resource/Category:H_shares +
, http://dbpedia.org/resource/Covaxin +
, http://dbpedia.org/resource/Sinopharm +
|
| http://dbpedia.org/property/altname
|
Sinopharm Group
|
| http://dbpedia.org/property/areaServed
|
China
|
| http://dbpedia.org/property/assets
|
1.38267E11
|
| http://dbpedia.org/property/assetsYear
|
2015
|
| http://dbpedia.org/property/equity
|
3.0052E10
|
| http://dbpedia.org/property/equityYear
|
2015
|
| http://dbpedia.org/property/footnotes
|
in a consolidated basis; equity and profit excluded minority interests; in Hong Kong Financial Reporting Standards
|
| http://dbpedia.org/property/founder
|
http://dbpedia.org/resource/China_National_Pharmaceutical_Group +
|
| http://dbpedia.org/property/incomeYear
|
2015
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Pharmaceutical +
|
| http://dbpedia.org/property/isin
|
CNE100000FN7
|
| http://dbpedia.org/property/l
|
Sinopharm Holding
, Sinopharm Holding Joint-Stock Limited Company
|
| http://dbpedia.org/property/location
|
Sinopharm Plaza
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Shanghai +
|
| http://dbpedia.org/property/locationCountry
|
China
|
| http://dbpedia.org/property/logo
|
Sinopharm Group logo.png
|
| http://dbpedia.org/property/logoAlt
|
logo of Sinopharm Group , with bilingual name on the right
|
| http://dbpedia.org/property/logoCaption
|
logo of Sinopharm Group , with bilingual name on the right
|
| http://dbpedia.org/property/logoSize
|
250
|
| http://dbpedia.org/property/name
|
Sinopharm Group
|
| http://dbpedia.org/property/netIncome
|
3.761E9
|
| http://dbpedia.org/property/netIncomeYear
|
2015
|
| http://dbpedia.org/property/operatingIncome
|
9.169E9
|
| http://dbpedia.org/property/order
|
st
|
| http://dbpedia.org/property/owner
|
Sinopharm Industrial Investment
|
| http://dbpedia.org/property/parent
|
Sinopharm Industrial Investment
|
| http://dbpedia.org/property/revenue
|
CNY 227.069 1,000,000,000
|
| http://dbpedia.org/property/revenueYear
|
2015
|
| http://dbpedia.org/property/s
|
国控股份有限公司
, 国药控股
, 国药控股股份有限公司
|
| http://dbpedia.org/property/subsid
|
http://dbpedia.org/resource/Sinopharm_CNMC +
|
| http://dbpedia.org/property/t
|
國控股份有限公司
, 國藥控股股份有限公司
, 國藥控股
|
| http://dbpedia.org/property/title
|
Sinopharm Group Co., Ltd.
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Chinese +
, http://dbpedia.org/resource/Template:Official_website +
, http://dbpedia.org/resource/Template:Hkex +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Ubl +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Aligned_table +
, http://dbpedia.org/resource/Template:Distinguish +
, http://dbpedia.org/resource/Template:Main +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Pharmaceutical_companies_of_China +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Chinese_brands +
, http://dbpedia.org/resource/Category:Fosun_International +
, http://dbpedia.org/resource/Category:H_shares +
, http://dbpedia.org/resource/Category:Retail_companies_of_China +
, http://dbpedia.org/resource/Category:Chinese_companies_established_in_2004 +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Hong_Kong_Stock_Exchange +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_2003 +
, http://dbpedia.org/resource/Category:Government-owned_companies_of_China +
, http://dbpedia.org/resource/Category:Privatization_in_China +
, http://dbpedia.org/resource/Category:Companies_based_in_Shanghai +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_China +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Sinopharm_Group?oldid=1117952037&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Sinopharm_Group_logo.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Sinopharm_Group +
|
| owl:sameAs |
http://www.wikidata.org/entity/Q7524930 +
, http://hy.dbpedia.org/resource/Sinopharm_Group +
, http://azb.dbpedia.org/resource/%D8%B3%DB%8C%D9%86%D9%88%D9%81%D8%A7%D8%B1%D9%85 +
, http://pt.dbpedia.org/resource/Sinopharm_Group +
, https://global.dbpedia.org/id/4uf4M +
, http://de.dbpedia.org/resource/Sinopharm_Group +
, http://dbpedia.org/resource/Sinopharm_Group +
, http://zh.dbpedia.org/resource/%E5%9C%8B%E8%97%A5%E6%8E%A7%E8%82%A1 +
, http://no.dbpedia.org/resource/Sinopharm_Group +
, http://ru.dbpedia.org/resource/Sinopharm_Group +
, http://fa.dbpedia.org/resource/%D8%B3%DB%8C%D9%86%D9%88%D9%81%D8%A7%D8%B1%D9%85 +
, http://fr.dbpedia.org/resource/Sinopharm +
, http://eu.dbpedia.org/resource/Sinopharm_Group +
, http://sv.dbpedia.org/resource/Sinopharm_Group +
|
| rdfs:comment |
Die Sinopharm Group ist ein chinesisches P … Die Sinopharm Group ist ein chinesisches Pharmaunternehmen. Die Muttergesellschaft der Sinopharm Group war Sinopharm Industrial Investment, ein 51 zu 49-Joint Venture zwischen der staatlichen und der privaten Fosun Pharmaceutical. Die Sinopharm-Gruppe erforscht und entwickelt, produziert, vertreibt und vermarktet Arzneimittel und andere Gesundheitsprodukte. Die Sinopharm Group verwaltet Fabriken, Forschungslabors, Plantagen der traditionellen chinesischen Medizin sowie Marketing- und Vertriebsnetzwerke, die sich über ganz China erstrecken.erke, die sich über ganz China erstrecken.
, Sinopharm Group Co., Ltd. är ett kinesiskt … Sinopharm Group Co., Ltd. är ett kinesiskt läkemedelsföretag. Dess huvudägare är Sinopharm Industrial Investment, ett samriskföretag mellan det statliga och det privata . Sinopharm Group forskar om och utvecklar och tillverkar mediciner och vacciner. Företaget är sedan 2009 noterat på Hongkongbörsen.t är sedan 2009 noterat på Hongkongbörsen.
, Sinopharm Group Co., Ltd. (國藥控股股份有限公司, «Си … Sinopharm Group Co., Ltd. (國藥控股股份有限公司, «Синофарм Груп» или «Синофарм Холдинг») — одна из крупнейших фармацевтических компаний Китая и Азии; входит в «большую тройку» фармацевтических компаний страны (наряду с China Resources Pharmaceutical Group и Shanghai Pharmaceuticals) и в сотню крупнейших компаний Китая. Основана в 2003 году, штаб-квартира расположена в Шанхае, контрольный пакет принадлежит China National Pharmaceutical Group.лежит China National Pharmaceutical Group.
, O Sinopharm Group é uma empresa farmacêuti … O Sinopharm Group é uma empresa farmacêutica chinesa. As empresas controladoras do Grupo Sinopharm são a Sinopharm Industrial Investment, uma joint venture do China National Pharmaceutical Group, de propriedade estatal, e a Fosun Pharmaceutical, empresa privada.e a Fosun Pharmaceutical, empresa privada.
, Sinopharm Group Co., Ltd. is a Chinese pha … Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.re of Sinopharm Group itself was unlisted.
, 國藥控股股份有限公司（英文名：Sinopharm Group Co., Ltd.，簡稱：“國藥控股”，港交所：1099）是中國國藥集團旗下的核心企業。
, Sinopharm Group, Txinako sendagai biologiko arloko produktuen enpresa bat da. 2003an sortua, Shanghai hirian egoitza nagusia du.
, Sinopharm est un groupe pharmaceutique chi … Sinopharm est un groupe pharmaceutique chinois fondé en 2003. C'est la plus grande entreprise pharmaceutique en Chine, détenue conjointement par la China National Pharmaceutical Group Corporation et Fosun International. Son chiffre d'affaires en 2013 a atteint les 33,2 milliards de dollars US. Ils développent le vaccin BBIBP-CorV, à particules virales inactivées lors de la Pandémie de Covid-19.nactivées lors de la Pandémie de Covid-19.
|
| rdfs:label |
Sinopharm
, Sinopharm Group
, 國藥控股
|
